Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetes
- Ana Lledó-Delgado
- Paula Preston-Hurlburt
- Lauren Higdon
- Alex Hu
- Eddie James
- Noha Lim
- S. Alice Long
- James McNamara
- Hai Nguyen
- Elisavet Serti
- Tomokazu S. Sumida
- Kevan C. Herold
2025-05-30